A Study of Cebranopadol for the Treatment of Acute Pain After Abdominoplasty (NCT06545097) | Clinical Trial Compass
CompletedPhase 3
A Study of Cebranopadol for the Treatment of Acute Pain After Abdominoplasty
United States279 participantsStarted 2024-09-03
Plain-language summary
The purpose of this study is to evaluate the efficacy and safety of Cebranopadol for acute pain after a Abdominoplasty.
Who can participate
Age range18 Years – 75 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Key Inclusion Criteria:
* Scheduled to undergo full abdominoplasty procedure without liposuction or other collateral procedures, using anesthesiologic and surgical procedures planned as described in this protocol.
* Must be able to adhere to the visit schedule, complete all study assessments, and protocol requirements including self-reported questionnaires.
Key Exclusion Criteria:
* Any clinically significant disease, medical condition or laboratory finding that in the investigator's opinion may interfere with the study procedures or data integrity or compromise the safety of the subject.
* Subject has a current painful condition that could confound the interpretation of efficacy, safety or tolerability data in the study, in the opinion of the investigator.
* History of allergy, hypersensitivity or intolerance to any opioid analgesics or anesthetics, including opioid-induced nausea or vomiting.